Unity Biotechnology, Inc. (33) | Human Resources (13)

Browse by Subcategory

Recent Contracts

Transition and Separation Agreement, dated December 12, 2020, by and between Nathaniel David and Unity Biotechnology, Inc (Filed With SEC on March 23, 2021)
Executive Employment Agreement, dated August 1, 2020, by and between Unity Biotechnology, Inc. and Lynne Sullivan (Filed With SEC on November 4, 2020)
Amended and Restated Non-Employee Director Compensation Program (effective as of March 30, 2020) (Filed With SEC on May 7, 2020)
Amendment to Executive Employment Agreement, dated September 1, 2020, by and between Unity Biotechnology, Inc. and Lynne Sullivan (Filed With SEC on November 4, 2020)
Employment Agreement, dated March 30, 2020, by and between Unity Biotechnology, Inc. and Anirvan Ghosh (Filed With SEC on March 30, 2020)
Amendment to Employment Agreement, dated March 9, 2020, by and between Unity Biotechnology, Inc. and Nathaniel E. David (Filed With SEC on March 11, 2020)
Amendment to Employment Agreement, dated March 9, 2020, by and between Unity Biotechnology, Inc. and Robert C. Goeltz II (Filed With SEC on March 11, 2020)
Amendment to Employment Agreement, dated March 9, 2020, by and between Unity Biotechnology, Inc. and Jamie Dananberg (Filed With SEC on March 11, 2020)
Amendment to Employment Agreement, dated March 9, 2020, by and between Unity Biotechnology, Inc. and Daniel G. Marquess (Filed With SEC on March 11, 2020)
Amendment to Employment Agreement, dated March 9, 2020, by and between Unity Biotechnology, Inc. and Tamara L. Tompkins (Filed With SEC on March 11, 2020)
Amended and Restated Non-Employee Director Compensation Program (effective as of June 13, 2019) (Filed With SEC on August 7, 2019)
Amended and Restated Non-Employee Director Compensation Program (effective as of March 14, 2019) (Filed With SEC on May 8, 2019)
Amended and Restated Non-Employee Director Compensation Program (Effective January 1, 2019) (Filed With SEC on March 6, 2019)